Stomach acid drops with age, intrinsic factor production drops with it, and dietary B12 absorption follows
In the ATTAIN-1 phase 3 trial, orforglipron achieved 7.5%, 8.4%, and 11.2% weight loss after 72 weeks of treatment with 6 mg, 12 mg, and 36 mg, respectively, compared to 2.1% with placebo [32]
Risks and Unknowns Intellectual honesty requires acknowledging what we do not know: Less studied: Clinical trials tested specific doses (0.25mg for 4 weeks, then up)
While injection site discomfort is typically minimal and transient, GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists are associated with other side effects that patients should understand before starting treatment
Cellular Stress Response Research: Exploring how it affects gene expression related to apoptosis and autophagy at the cellular level could uncover novel pathways for promoting cellular repair, resilience, and insights into longevity research
Why Are More People Choosing Semaglutide Over Traditional Dieting